Kunming Pharmaceuticals, Inc.
Clinical trials sponsored by Kunming Pharmaceuticals, Inc., explained in plain language.
-
Malaria pill may calm lupus skin flares, new trial hopes
Disease control Not yet recruitingThis study tests if dihydroartemisinin, a malaria drug, can safely reduce skin lesions in people with discoid lupus erythematosus (DLE). About 100 adults aged 18-65 will receive either the study drug or an active comparator for 24 weeks. The main goal is to measure changes in the…
Phase: PHASE2 • Sponsor: Kunming Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 02, 2026 22:07 UTC
-
Could a Plant-Based injection calm delirium? early safety trial begins
Symptom relief Not yet recruitingThis study tests a new injection called gastrodin in 54 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use it to ease symptoms of delirium, a sudden confused state. Participants will be closely monitored for side effects.
Phase: PHASE1 • Sponsor: Kunming Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC